SCHeLTI-LIFE TREE - Mothers - Control
The population is composed of women between 20 to 42 years of age who are: registered Shanghai residents, married to a registered Shanghai resident, or non-residents but have lived in Shanghai for at least 5 years, less than 14 weeks pregnant with one child, and planning to deliver in a participating study hospital. In the control group, participants receive usual prenatal and childhood care, but no study health promotion intervention.
The population is composed of women between 20 to 42 years of age who are: registered Shanghai residents, married to a registered Shanghai resident, or non-residents but have lived in Shanghai for at least 5 years, less than 14 weeks pregnant with one child, and planning to deliver in a participating study hospital. In the control group, participants receive usual prenatal and childhood care, but no study health promotion intervention.
-
Sex
-
Women
-
Minimum age
-
20
-
Maximum age
-
42
-
Pregnant Women
-
-
Newborns
-
-
Twins
-
-
Countries
-
-
Territory
-
Shanghai
-
Ethnic Origin
-
-
Health Status
-
- Women are excluded from the study if they have HIV, Hepatitis B, Hepatitis C, major heart conditions, thalassemia major, cystic fibrosis, pre-existing type 1 diabetes mellitus, type 2 diabetes mellitus, or chronic medication-dependant hypertension.
-
Other Criteria
-
Participating women must be Mandarin speakers and less than 14 weeks pregnant.
Women are excluded if they plan to move out participating Shanghai districts chosen for the study within five years, abuse drugs, or have multiple pregnancies.
-
Supplementary Information about selection criteria
-
-
Sources of recruitment
-
-
Specific Population
-
-
Supplementary Information
-
Participants are recruited from one of the 42 maternal child health units located within the four designated Shanghai districts.
-
Number of Participants
-
2,250
-
Number of Participants with Biological Samples
-
2,250
-
Supplementary Information about selection criteria
-
Nonpregnant women: 900 participants
Pregnant women (< 14 weeks): 1350 participants
50% of 900 nonpregnant participants are expected to achieve a viable pregnancy within 1 year of enrolment and continue prenatal follow-up with the study.